EFNS guideline on the treatment of tension-type headache - report of an EFNS task force

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

EFNS guideline on the treatment of tension-type headache - report of an EFNS task force. / Bendtsen, L; Kalsmose-Hjelmborg, Simon Evers; Linde, M.; Mitsikostas, D.D.; Sandrini, G.; Schoenen, J.; Evers, S; Linde, Marianne; Mitsikostas, D D; Sandrini, G; Schoenen, J; EFNS.

I: European Journal of Neurology, Bind 17, Nr. 11, 2010, s. 1318-25.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Bendtsen, L, Kalsmose-Hjelmborg, SE, Linde, M, Mitsikostas, DD, Sandrini, G, Schoenen, J, Evers, S, Linde, M, Mitsikostas, DD, Sandrini, G, Schoenen, J & EFNS 2010, 'EFNS guideline on the treatment of tension-type headache - report of an EFNS task force', European Journal of Neurology, bind 17, nr. 11, s. 1318-25. https://doi.org/10.1111/j.1468-1331.2010.03070.x

APA

Bendtsen, L., Kalsmose-Hjelmborg, S. E., Linde, M., Mitsikostas, D. D., Sandrini, G., Schoenen, J., Evers, S., Linde, M., Mitsikostas, D. D., Sandrini, G., Schoenen, J., & EFNS (2010). EFNS guideline on the treatment of tension-type headache - report of an EFNS task force. European Journal of Neurology, 17(11), 1318-25. https://doi.org/10.1111/j.1468-1331.2010.03070.x

Vancouver

Bendtsen L, Kalsmose-Hjelmborg SE, Linde M, Mitsikostas DD, Sandrini G, Schoenen J o.a. EFNS guideline on the treatment of tension-type headache - report of an EFNS task force. European Journal of Neurology. 2010;17(11):1318-25. https://doi.org/10.1111/j.1468-1331.2010.03070.x

Author

Bendtsen, L ; Kalsmose-Hjelmborg, Simon Evers ; Linde, M. ; Mitsikostas, D.D. ; Sandrini, G. ; Schoenen, J. ; Evers, S ; Linde, Marianne ; Mitsikostas, D D ; Sandrini, G ; Schoenen, J ; EFNS. / EFNS guideline on the treatment of tension-type headache - report of an EFNS task force. I: European Journal of Neurology. 2010 ; Bind 17, Nr. 11. s. 1318-25.

Bibtex

@article{9edbd28576134ebf8c1527dcc2e49a54,
title = "EFNS guideline on the treatment of tension-type headache - report of an EFNS task force",
abstract = "Background: Tension-type headache (TTH) is the most prevalent headache type and is causing a high degree of disability. Treatment of frequent TTH is often difficult. Objectives: To give evidence-based or expert recommendations for the different treatment procedures in TTH based on a literature search and the consensus of an expert panel. Methods: All available medical reference systems were screened for the range of clinical studies on TTH. The findings in these studies were evaluated according to the recommendations of the EFNS resulting in level A, B or C recommendations and good practice points. Recommendations: Non-drug management should always be considered although the scientific basis is limited. Information, reassurance and identification of trigger factors may be rewarding. Electromyography (EMG) biofeedback has a documented effect in TTH, whilst cognitive-behavioural therapy and relaxation training most likely are effective. Physical therapy and acupuncture may be valuable options for patients with frequent TTH, but there is no robust scientific evidence for efficacy. Simple analgesics and non-steroidal anti-inflammatory drugs are recommended for the treatment of episodic TTH. Combination analgesics containing caffeine are drugs of second choice. Triptans, muscle relaxants and opioids should not be used. It is crucial to avoid frequent and excessive use of analgesics to prevent the development of medication-overuse headache. The tricyclic antidepressant amitriptyline is drug of first choice for the prophylactic treatment of chronic TTH. Mirtazapine and venlafaxine are drugs of second choice. The efficacy of the prophylactic drugs is often limited, and treatment may be hampered by side effects",
author = "L Bendtsen and Kalsmose-Hjelmborg, {Simon Evers} and M. Linde and D.D. Mitsikostas and G. Sandrini and J. Schoenen and S Evers and Marianne Linde and Mitsikostas, {D D} and G Sandrini and J Schoenen and Lars Bendtsen",
note = "{\textcopyright} 2010 The Author(s). Journal compilation {\textcopyright} 2010 EFNS.",
year = "2010",
doi = "http://dx.doi.org/10.1111/j.1468-1331.2010.03070.x",
language = "English",
volume = "17",
pages = "1318--25",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell",
number = "11",

}

RIS

TY - JOUR

T1 - EFNS guideline on the treatment of tension-type headache - report of an EFNS task force

AU - Bendtsen, L

AU - Kalsmose-Hjelmborg, Simon Evers

AU - Linde, M.

AU - Mitsikostas, D.D.

AU - Sandrini, G.

AU - Schoenen, J.

AU - Evers, S

AU - Linde, Marianne

AU - Mitsikostas, D D

AU - Sandrini, G

AU - Schoenen, J

AU - EFNS

N1 - © 2010 The Author(s). Journal compilation © 2010 EFNS.

PY - 2010

Y1 - 2010

N2 - Background: Tension-type headache (TTH) is the most prevalent headache type and is causing a high degree of disability. Treatment of frequent TTH is often difficult. Objectives: To give evidence-based or expert recommendations for the different treatment procedures in TTH based on a literature search and the consensus of an expert panel. Methods: All available medical reference systems were screened for the range of clinical studies on TTH. The findings in these studies were evaluated according to the recommendations of the EFNS resulting in level A, B or C recommendations and good practice points. Recommendations: Non-drug management should always be considered although the scientific basis is limited. Information, reassurance and identification of trigger factors may be rewarding. Electromyography (EMG) biofeedback has a documented effect in TTH, whilst cognitive-behavioural therapy and relaxation training most likely are effective. Physical therapy and acupuncture may be valuable options for patients with frequent TTH, but there is no robust scientific evidence for efficacy. Simple analgesics and non-steroidal anti-inflammatory drugs are recommended for the treatment of episodic TTH. Combination analgesics containing caffeine are drugs of second choice. Triptans, muscle relaxants and opioids should not be used. It is crucial to avoid frequent and excessive use of analgesics to prevent the development of medication-overuse headache. The tricyclic antidepressant amitriptyline is drug of first choice for the prophylactic treatment of chronic TTH. Mirtazapine and venlafaxine are drugs of second choice. The efficacy of the prophylactic drugs is often limited, and treatment may be hampered by side effects

AB - Background: Tension-type headache (TTH) is the most prevalent headache type and is causing a high degree of disability. Treatment of frequent TTH is often difficult. Objectives: To give evidence-based or expert recommendations for the different treatment procedures in TTH based on a literature search and the consensus of an expert panel. Methods: All available medical reference systems were screened for the range of clinical studies on TTH. The findings in these studies were evaluated according to the recommendations of the EFNS resulting in level A, B or C recommendations and good practice points. Recommendations: Non-drug management should always be considered although the scientific basis is limited. Information, reassurance and identification of trigger factors may be rewarding. Electromyography (EMG) biofeedback has a documented effect in TTH, whilst cognitive-behavioural therapy and relaxation training most likely are effective. Physical therapy and acupuncture may be valuable options for patients with frequent TTH, but there is no robust scientific evidence for efficacy. Simple analgesics and non-steroidal anti-inflammatory drugs are recommended for the treatment of episodic TTH. Combination analgesics containing caffeine are drugs of second choice. Triptans, muscle relaxants and opioids should not be used. It is crucial to avoid frequent and excessive use of analgesics to prevent the development of medication-overuse headache. The tricyclic antidepressant amitriptyline is drug of first choice for the prophylactic treatment of chronic TTH. Mirtazapine and venlafaxine are drugs of second choice. The efficacy of the prophylactic drugs is often limited, and treatment may be hampered by side effects

U2 - http://dx.doi.org/10.1111/j.1468-1331.2010.03070.x

DO - http://dx.doi.org/10.1111/j.1468-1331.2010.03070.x

M3 - Journal article

VL - 17

SP - 1318

EP - 1325

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 11

ER -

ID: 34146255